Term
Recurrent episodes of coughing, +/- wheezing, breathlessness and chest tightness
These episodes are usually associated with widespread but variable airflow obstruction that is OFTEN reversible either spontaneously or with treatment |
|
Definition
|
|
Term
Produce mediators that cause allergic inflammation |
|
Definition
|
|
Term
Produce mediators criticak to defend against infection |
|
Definition
|
|
Term
Asthma -imbalance of Th1 and Th2 |
|
Definition
overexpression of Th2 and underexpression of Th1 |
|
|
Term
Two major environmental factors of asthma |
|
Definition
1. Airborne allergens
2. Viral respitatory infections - implicated during infancy |
|
|
Term
Other risk factors of asthma |
|
Definition
tobacco smoke
air pollution
occupational exposures
diet low in antioxidants and omega3 fatty acid |
|
|
Term
Asthma Bronchoconstriction caused from: |
|
Definition
IgE dependent release of mediators from mast cells
-histamime
-tryptase
-leukotrienes
-prostaglandins
+++less defined=NSAIDS, cold air, exercise |
|
|
Term
Pathophysiology of asthma |
|
Definition
1. Airway edema/inflammation
2. airway hyperresponsiveness
3. airway remodeling |
|
|
Term
Diagnostic tool for asthma |
|
Definition
Spirometry: repeated measurements
-FEV1 dec
-FEV6 (sub for FVC)
-FVC (preserved or dec)
-FEV1/FVC dec
+++tested before and after SABD to assess reversibility |
|
|
Term
Spirometry results that indicate asthma |
|
Definition
1. FEV1>200 ml and 12% change from baseline
2. some show reversibility after 2-3 wks on ICS
-need follow up spiro |
|
|
Term
Complete Pulmonary function tests: |
|
Definition
Spirometry
flow loops
lung vol
airway resistance
DLCO |
|
|
Term
Other diagnostics for Asthma |
|
Definition
Complete PFTs
ABG
Sputum eosinophilia
FeNO measurements
Bronchoprovocation
Allergy testing
serologies
GERD testing
CT sinus
|
|
|
Term
|
Definition
Monitoring tool, not diagnostic for asthma
green (80-100%) good
yellow (50-80%) caution
Red (<50%) danger
|
|
|
Term
Methacholine is adminstered in incremental doses up to max dose of 16 mg/ml
20% dec in FEV1, up to 4mg/ml =positive for bronchial hyperresponsiveness
Avoid performing test is FEV1 less than 65-70% at baseline |
|
Definition
Bronchoprovocation - methacholine challenge |
|
|
Term
DD of asthma in infants and children |
|
Definition
-allergic rhinitis and sinusitis
-FB
-VCD
-Vascular ring or laryngeal webs
-laryngotracheomalacia, tracheal stenosis, bronchostenosis
-large nodes, tumor
-viral bronchitis/brinchiolitis
-CF
-Bronchopulmonary dysplasia
-CHD |
|
|
Term
|
Definition
ABOA
Eosinophilic bronchitis
Post infectious cough
GERD
PND/ Sinus disease
tumors
cardiac
VCD
In acute setting
Bronchiectasis
aspergillus (fungal)
occupational lung disease
|
|
|
Term
Once diagnosis is established next:
|
|
Definition
1. Identify percipiating factors
2. identify comorbid that may aggravate asthma
3.classify asthma severity using impairment and risk domains
4. assses the patients knoledge and skills for self management |
|
|
Term
1. Symptoms 2x a week
2. <2nocturnal awakenings
3. use of SABA fewer than 2xa week
4. no change in activities
5. one, or no exacerbations requiring PO steroids
6. FEV1 b/w exacerbations that is normal |
|
Definition
|
|
Term
1. Symp >2x a week
2. 3-4 nocturnal awakenings per mo
3. use of SABA > 2 x a week not daily
4. minor interference with ADLs
5. FEV1 normal (>80% predicted)
6. 2 or more exacerbations requiring PO steroids per year |
|
Definition
|
|
Term
1. Symptoms daily
2. Nocturnal awakenings more than once a wk
3. daily need for SABA
4. Some limitations in nl activities
5. FEV1 b/w 60-80% predicted
6. FEV1/FVC reduced below normal |
|
Definition
Moderate persistent asthma |
|
|
Term
1. continuous symptoms
2. nocturnal awakenings nightly
3. need for SABA multiple times daily
4. extreme limitation in activity
5.FEV1 <60% predicted
6. FEV1/FVC reduced below normal
7. 2 or more exacerbations requiring oral steroids per year |
|
Definition
|
|
Term
Monoclonal ABX that binds to IGE
Must have ALLRGIC ASTHMA and >12 yo
mod-severe persistant asthma
High IGE
(+) allergy testing
SQ injection based on BMI
Steroid sparing |
|
Definition
|
|
Term
High Risk Asthma patients |
|
Definition
1. severe air flow obstruction
2. persistent severe airflow obstruction
3. 2 or + ED visits/yr
4. any hx of intubation or ICU
5. pt feels danger or fear of asthma
6. FEMALE, NONWHITE, nonuse of ICS
7. Smokers + drugs
8. depression, stress, low socioeco
9. attitudes about medication use
|
|
|
Term
|
Definition
1. Reduce impairment
2. reduce risk
3. periodic assessments |
|
|
Term
Education points for asthma patients: |
|
Definition
1. Basic facts
2. Roles of meds and differeneces in meds
3. Patient skills |
|
|
Term
Risk/complications of asthma: |
|
Definition
1. death
2. fixed airway obstruction
3. status asthmaticus |
|
|
Term
Different stages of status asthmaticus |
|
Definition
stage 1: SaO2 no, hypervent, PO2
Stage 2: Hypervent Hypoxia--> close monitor IRU
Stage 3: PCO2 nl "false", resp muscle fatigue, hypoxia=ICU
Stage 4: PCO2 high, PO2 low = ICU |
|
|
Term
Signs/symp:
snoring
witness apnea
EDS
insomnia
non-restorative sleep
GERD
morning headache |
|
Definition
|
|
Term
No lung in breath for >/+ to 10 sec |
|
Definition
|
|
Term
airflow reduction + drop in O2 by at least 4% |
|
Definition
|
|
Term
Apnea Hypopnea Index (AHI) |
|
Definition
<5/hr = normal
5-20 = mild - mod
20-40 = mod to severe
>40 = very severe |
|
|
Term
Test of upper air resistence + arousal
snore + arousal
Respiratory event related arousal
>15/hr abnormal |
|
Definition
Respiratory disturbance index |
|
|